FASIGYN

This brand name is authorized in Mexico, Singapore.

Active ingredients

The drug FASIGYN contains one active pharmaceutical ingredient (API):

1	Tinidazole UNII 033KF7V46H - TINIDAZOLE
	Tinidazole is active against both protozoa and obligate anaerobic bacteria. The activity against protozoa involves Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The mode of action of tinidazole against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis.
	Read more about Tinidazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FASIGYN Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XD02	Tinidazole	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives
Discover more medicines within J01XD02
P01AB02	Tinidazole	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01A Agents against amoebiasis and other protozoal diseases → P01AB Nitroimidazole derivatives
Discover more medicines within P01AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	76708
SG	Health Sciences Authority	10693P